Cargando…

Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection

SARS CoV-2, a causative agent of human respiratory tract infection, was first identified in late 2019. It is a newly emerging viral disease with unsatisfactory treatments. The virus is highly contagious and has caused pandemic globally. The number of deaths is increasing exponentially, which is an a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahu, Utkarsha, Biswas, Debasis, Singh, Anirudh Kumar, Khare, Prashant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096142/ https://www.ncbi.nlm.nih.gov/pubmed/33969150 http://dx.doi.org/10.1007/s13337-021-00687-2

Ejemplares similares

Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection
por: Khare, Prashant, et al.
Publicado: (2020)

Designing of multi-epitope chimeric vaccine using immunoinformatic platform by targeting oncogenic strain HPV 16 and 18 against cervical cancer
por: Kumar, Anoop, et al.
Publicado: (2022)

Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates
por: Jain, Surbhi, et al.
Publicado: (2022)

Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
por: Lee, Eunjin, et al.
Publicado: (2021)

Are Countries Becoming Better at SARS-CoV-2 Genomic Surveillance?
por: Mahanta, Utkarsha, et al.
Publicado: (2022)

Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement
por: Amirfakhryan, Hamideh, et al.
Publicado: (2021)

Genomic, proteomic and metabolomic profiling of severe acute respiratory syndrome-Coronavirus-2
por: Mathew, Bijina J., et al.
Publicado: (2022)

Role of Cytokines in Experimental and Human Visceral Leishmaniasis
por: Samant, Mukesh, et al.
Publicado: (2021)

Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
por: Carrillo, Jorge, et al.
Publicado: (2021)

SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology
por: Sahu, Amit Kumar, et al.
Publicado: (2021)

Epidemiology, transmission and pathogenesis of SARS-CoV-2
por: Sindhuja, Tulasi, et al.
Publicado: (2022)

In silico identification of promising inhibitor against RNA-dependent RNA polymerase target of SARS-CoV-2
por: Singh, Pushpendra, et al.
Publicado: (2021)

Cell and animal models of SARS-CoV-2 pathogenesis and immunity
por: Leist, Sarah R., et al.
Publicado: (2020)

Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis
por: Ghosh, Dipanjan, et al.
Publicado: (2022)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis
por: Singh, Lakhveer, et al.
Publicado: (2021)

Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
por: Saravanan, Udhaya Bharathy, et al.
Publicado: (2022)

Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis
por: Kang, Yeon-Woo, et al.
Publicado: (2021)

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
por: Gusev, Evgenii, et al.
Publicado: (2022)

An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
por: Hembram, Padmalochan
Publicado: (2021)

Systemic review of CNS involvement and its manifestations in SARS-CoV2 positive patients
por: Yadav, Ramakant, et al.
Publicado: (2021)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
por: An, Xingyue, et al.
Publicado: (2021)

In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis
por: Tiwari, Ritudhwaj, et al.
Publicado: (2020)

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
por: Harrison, Andrew G., et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
por: Bharadwaj, Shiv, et al.
Publicado: (2021)

Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations
por: Jha, Niraj Kumar, et al.
Publicado: (2021)

Associated pathogenesis of bladder cancer and SARS-CoV-2 infection: a treatment strategy
por: Singh, Mukul Kumar, et al.
Publicado: (2021)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021)

Innate immune recognition against SARS-CoV-2
por: Yamada, Taisho, et al.
Publicado: (2023)

Unfolding issues of immunity against SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Viral pathogenesis of SARS-CoV-2 infection and male reproductive health
por: Roychoudhury, Shubhadeep, et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19
por: Sharma, Homa Nath, et al.
Publicado: (2021)

Non-immune Prophylaxis Against COVID-19 by Targeting Tolerance for Angiotensin II-Triggered SARS-CoV-2 Pathogenesis
por: Dubina, Michael V.
Publicado: (2022)

Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection
por: Gao, Xiang, et al.
Publicado: (2022)

Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection
por: Behura, Assirbad, et al.
Publicado: (2023)

Neurological Involvements of SARS-CoV2 Infection
por: Gasmi, Amin, et al.
Publicado: (2020)

Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions
por: Bunders, Madeleine J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0v2e6rcoi7bn3sj2h318vsacrg